Impact of comprehensive and intensive treatment of risk factors concerning cardiovascular mortality in secondary prevention: MIRVAS study
Completed
- Conditions
- Secondary prevention of cardiovascular diseaseCirculatory System
- Registration Number
- ISRCTN93700442
- Lead Sponsor
- a Princesa University Hospital (Hospital Universitario de La Princesa) (Spain)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 247
Inclusion Criteria
1. Both males and females, from 18 to 80 years old
2. Patients admitted to the hospital for acute coronary syndrome (with or without ST-segment elevation) or an ischaemic stroke
Exclusion Criteria
1. Refusal or inability to participate in the follow-up (displaced patients or with reduced mobility)
2. Life expectancy of less than 12 months
3. Severe cognitive deterioration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The following were assessed at three-year follow-up:<br>1. Cardiovascular mortality and cardiovascular morbimortality, which included the following events: 1.1. Cardiovascular death<br>1.2. Acute coronary syndrome with or without ST-segment elevation<br>1.3. Acute stroke (ischaemic or haemorrhagic)<br>1.4. Revascularisation in any area<br>1.5. Amputation as a result of peripheral ischaemia<br>2. Admittance due to heart failure<br>3. Control of risk factors<br> <br>All episodes were understood as such if they had a clinical report to back them up. The assessments were carried out by an unblinded member of the research group.
- Secondary Outcome Measures
Name Time Method The following were assessed at 1 and 3 years:<br>1. Percentage of patients who reached the optimal control of each risk factor <br>2. Percentage of pharmacological interventions recommended by international guidelines for secondary prevention of cardiovascular risk received in each arm